SIB-Norwegian Version, Validation and Reliability Study

Sykehuset Innlandet HF59 enrolled

Overview

The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Dementia Diagnostic Tests, Routine

Interventions

Diagnostic ScreeningBEHAVIORAL

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Dementia, mild to severe. * Nursing Home resident Exclusion Criteria: * No ability to write or read. * Physical handicapped, unable to use hands.

Locations (1)

Sykehuset Innlandet HF - Sanderud

Ottestad, Oppland, Norway

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.